Evidence map›Paper›PMID 27812541›Full record

ArticleJCI insight2016

Muscle oxidative phosphorylation quantitation using creatine chemical exchange saturation transfer (CrCEST) MRI in mitochondrial disorders.

Catherine DeBrosse, Ravi Prakash Reddy Nanga, Neil Wilson, Kevin D'Aquilla, Mark Elliott, Hari Hariharan, Felicia Yan, Kristin Wade, Sara Nguyen, Diana Worsley and 12 more

3 registry-linked trialsAbstract read
In one paragraph

Article in JCI insight, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04817111 phase2completednot on this mapstarted 2021, after this paper: background citation

A Phase 2a Study of NAD+ Precursor Supplementation in Friedreich's Ataxia

TypeinterventionalSponsorMetro International Biotech, LLCRan2021 to 2022Enrolled7ConditionsFriedreich AtaxiaArmsMIB-626
NCT05250375 recruitingnot on this mapstarted 2017, after this paper: background citation

Natural History Study of Mitochondrial Myopathy

Typeobservational_patient_registrySponsorChildren's Hospital of PhiladelphiaRan2017 to 2030Enrolled1,300ConditionsPrimary Mitochondrial Disease
NCT05569122 phase1recruitingnot on this mapstarted 2023, after this paper: background citation

The Utility of pGz in Primary Mitochondrial Disorders

TypeinterventionalSponsorChildren's Hospital of PhiladelphiaRan2023 to 2028Enrolled90ConditionsMitochondrial Myopathies, Mitochondrial DiseasesArmsCardiopulmonary Exercise Testing, pGz Bed, Gentle Jogger, Exercise Pedal, Lumason® contrast agent
3 · Its place in the literature

Who cites it

32 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Article
  7. Quantitative Assessment of Peripheral Oxidative Metabolism With a New DynamicJournal of magnetic resonance imaging : JMRI · 2024
    Article
  8. Review
  9. Article
  10. Biogenic Imaging Contrast Agents.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2023
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Catherine DeBrosseCenter for Magnetic Resonance and Optical Imaging, Department of Radiology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Ravi Prakash Reddy NangaCenter for Magnetic Resonance and Optical Imaging, Department of Radiology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Neil WilsonCenter for Magnetic Resonance and Optical Imaging, Department of Radiology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Kevin D'AquillaCenter for Magnetic Resonance and Optical Imaging, Department of Radiology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Mark ElliottCenter for Magnetic Resonance and Optical Imaging, Department of Radiology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Hari HariharanCenter for Magnetic Resonance and Optical Imaging, Department of Radiology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Felicia YanDivision of Endocrinology and Diabetes, The Children's Hospital of Philadelphia.
Kristin WadeDivision of Endocrinology and Diabetes, The Children's Hospital of Philadelphia.
Sara NguyenDivision of Endocrinology and Diabetes, The Children's Hospital of Philadelphia.
Diana WorsleyDivision of Endocrinology and Diabetes, The Children's Hospital of Philadelphia.
Chevonne Parris-SkeeteDivision of Endocrinology and Diabetes, The Children's Hospital of Philadelphia.
Elizabeth McCormickDivision of Human Genetics, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Rui XiaoDepartment of Biostatistics and Epidemiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Zuela Zolkipli CunninghamDepartment of Neurology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Lauren FishbeinDivision of Endocrinology, Metabolism, and Diabetes, University of Colorado School of Medicine, Aurora, Colorado, USA.
Katherine L NathansonDivision of Translational Medicine and Human Genetics, Department of Medicine, Perelman School of Medicine, University of Pennsylvania.
David R LynchDepartment of Neurology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Virginia A StallingsDivision of Gastroenterology, Hepatology, and Nutrition, The Children's Hospital of Philadelphia.
Marc YudkoffDivision of Human Genetics, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Marni J FalkDivision of Human Genetics, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Ravinder ReddyCenter for Magnetic Resonance and Optical Imaging, Department of Radiology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Shana E McCormackDivision of Endocrinology and Diabetes, The Children's Hospital of Philadelphia.

Funding

Phenotypic Diversity in COVID-19UL1TR001878 · NCATS · UNIVERSITY OF PENNSYLVANIA · PI FITZGERALD, GARRET A · 2016 to 2025
$102.4M
VIRAL VECTOR COREP30DK019525 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI MITCHELL A. LAZAR · 1986 to 2026
$48.3M
Institutional Clinical and Translational Science AwardUL1TR000003 · NCATS · UNIVERSITY OF PENNSYLVANIA · PI FITZGERALD, GARRET A · 2012 to 2015
$38.9M
Training and DisseminationP41EB015893 · NIBIB · UNIVERSITY OF PENNSYLVANIA · PI REDDY, RAVINDER · 2012 to 2019
$11.3M
The Intellectual and Developmental Disabilities Research Center at CHOP/PennU54HD086984 · NICHD · CHILDREN'S HOSP OF PHILADELPHIA · PI SCHULTZ, ROBERT THOMAS · 2016 to 2020
$6.3M
Career Development Program in Pediatric Diabetes Research (K12) at CHOPK12DK094723 · NIDDK · CHILDREN'S HOSP OF PHILADELPHIA · PI WILLI, STEVEN M · 2011 to 2020
$3.6M
Training in Structural, Physiologic and Functional MRIT32EB020087 · NIBIB · UNIVERSITY OF PENNSYLVANIA · PI JAMES C GEE, Chamith Sudesh Rajapakse · 2016 to 2026
$2.1M
Translational investigation of abnormal fat metabolism in mitochondrial diseaseK23DK102659 · NIDDK · CHILDREN'S HOSP OF PHILADELPHIA · PI MCCORMACK, SHANA ERIN · 2015 to 2017
$515k
NCATS NIH HHS UL1 TR000003NCATS NIH HHS UL1 TR001878NIBIB NIH HHS P41 EB015893NIBIB NIH HHS T32 EB020087NICHD NIH HHS U54 HD086984NIDDK NIH HHS K12 DK094723NIDDK NIH HHS K23 DK102659NIDDK NIH HHS P30 DK019525
6 · The paper itself

Abstract

Systemic mitochondrial energy deficiency is implicated in the pathophysiology of many age-related human diseases. Currently available tools to estimate mitochondrial oxidative phosphorylation (OXPHOS) capacity in skeletal muscle in vivo lack high anatomic resolution. Muscle groups vary with respect to their contractile and metabolic properties. Therefore, muscle group-specific estimates of OXPHOS would be advantageous. To address this need, a noninvasive creatine chemical exchange saturation transfer (CrCEST) MRI technique has recently been developed, which provides a measure of free creatine. After exercise, skeletal muscle can be imaged with CrCEST in order to make muscle group-specific measurements of OXPHOS capacity, reflected in the recovery rate (τCr) of free Cr. In this study, we found that individuals with genetic mitochondrial diseases had significantly (

Indexed as

Oxidative PhosphorylationAdultCreatineExercise TestFemaleHumansMagnetic Resonance ImagingMaleMiddle AgedMitochondrial DiseasesMitochondria, MuscleMuscle, SkeletalPhosphocreatinePhosphorylationCreatinePhosphocreatine

Identifiers

PMID27812541
PMCPMC5085612

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.